ArticleNature communications2026
Living sensor display implanted on skin for long-term biomarker monitoring.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The cutting-edge advancements in biomaterials under the guidance of intelligence and bionics.Regenerative biomaterials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
This study introduces an approach to biomarker monitoring through the development of a "Living Sensor Display" implanted on the skin, designed for long-term, continuous tracking of biomarkers, such as inflammatory cytokines. By leveraging the natural high selectivity and sensitivity of keratinocyte stem cells (KSCs) to environmental stimuli, we genetically engineered these cells to express fluorescent proteins in response to specific biomarker signals, specifically TNF-α signalling. This innovation allows for the real-time, non-invasive observation, with the only invasive step being the initial implantation, of biomarker levels directly from the skin surface. We constructed tissue-engineered skin with genetically modified KSCs and transplanted it onto mice, where it successfully engrafted long-term, matured to mimic human skin structures, and responsively indicated the presence of TNF-α through visible fluorescence. This living sensor could repeatedly detect inflammatory responses induced by TNF-α and lipopolysaccharides, highlighting its potential for monitoring various physiological and pathological processes over extended periods. This Living sensor display holds promise for advancing health monitoring and disease prevention strategies by enabling continuous, sensitive, and specific in vivo biomarker tracking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.